Australia's Oncosil Medical rises most in nearly 3 months on device insurance

Oncosil Medical

04/07/2022 02:42

** Shares of medical device co Oncosil Medical  OSL.AX  rise
as much as 40% to A$0.056, biggest intraday pct gain since April
13
    ** Bupa UK Insurance to provide reimbursement for
implantation of OncoSilTM device, says Oncosil (https://bit.ly/3R81A1r)
    ** OncoSilTM is OncoSil's medical device for locally
advanced pancreatic cancer 
    ** Co to work with other insurers to expand reimbursement
for treatment at The London Clinic and other private
institutions 
    ** Shares hit their highest level since June 9
    ** More than 2.7 mln shares change hands, vs the 30-day
average volume of about 840,000 shares
    ** Stock down 10% this year, as of last close
    

 (Reporting by Anan Ashraf in Bengaluru)
 ((Anan.Ashraf@thomsonreuters.com;))